Kodiak Sciences Inc. (BMV:KOD)

Mexico flag Mexico · Delayed Price · Currency is MXN
428.00
+28.00 (7.00%)
At close: Dec 4, 2025
187.25%
Market Cap29.04B
Revenue (ttm)n/a
Net Income (ttm)-3.99B
Shares Outn/a
EPS (ttm)-75.56
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6
Average Volume535
Open428.00
Previous Close400.00
Day's Range428.00 - 428.00
52-Week Range51.00 - 428.00
Betan/a
RSIn/a
Earnings DateMar 26, 2026

About Kodiak Sciences

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic mac... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2009
Employees 109
Stock Exchange Mexican Stock Exchange
Ticker Symbol KOD
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements